Correlation Between Palisade Bio and Vir Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Palisade Bio and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palisade Bio and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palisade Bio and Vir Biotechnology, you can compare the effects of market volatilities on Palisade Bio and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palisade Bio with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palisade Bio and Vir Biotechnology.

Diversification Opportunities for Palisade Bio and Vir Biotechnology

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Palisade and Vir is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Palisade Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palisade Bio are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Palisade Bio i.e., Palisade Bio and Vir Biotechnology go up and down completely randomly.

Pair Corralation between Palisade Bio and Vir Biotechnology

Given the investment horizon of 90 days Palisade Bio is expected to under-perform the Vir Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Palisade Bio is 1.04 times less risky than Vir Biotechnology. The stock trades about -0.47 of its potential returns per unit of risk. The Vir Biotechnology is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  1,011  in Vir Biotechnology on November 18, 2024 and sell it today you would lose (46.00) from holding Vir Biotechnology or give up 4.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Palisade Bio  vs.  Vir Biotechnology

 Performance 
       Timeline  
Palisade Bio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Palisade Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Vir Biotechnology 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vir Biotechnology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady forward indicators, Vir Biotechnology reported solid returns over the last few months and may actually be approaching a breakup point.

Palisade Bio and Vir Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Palisade Bio and Vir Biotechnology

The main advantage of trading using opposite Palisade Bio and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palisade Bio position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.
The idea behind Palisade Bio and Vir Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance